Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

OBJECTIVE: To compare natalizumab and fingolimod on both clinical and MRI outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) from 27 multiple sclerosis centers participating in the French follow-up cohort Observatoire of Multiple Sclerosis. METHODS: Patients with RRMS included i...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbin, Laetitia, Rousseau, Chloe, Jousset, Natacha, Casey, Romain, Debouverie, Marc, Vukusic, Sandra, De Sèze, Jerome, Brassat, David, Wiertlewski, Sandrine, Brochet, Bruno, Pelletier, Jean, Vermersch, Patrick, Edan, Gilles, Lebrun-Frenay, Christine, Clavelou, Pierre, Thouvenot, Eric, Camdessanché, Jean-Philippe, Tourbah, Ayman, Stankoff, Bruno, Al Khedr, Abdullatif, Cabre, Philippe, Papeix, Caroline, Berger, Eric, Heinzlef, Olivier, Debroucker, Thomas, Moreau, Thibault, Gout, Olivier, Bourre, Bertrand, Créange, Alain, Labauge, Pierre, Magy, Laurent, Defer, Gilles, Foucher, Yohann, Laplaud, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763805/
https://www.ncbi.nlm.nih.gov/pubmed/26826205
http://dx.doi.org/10.1212/WNL.0000000000002395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763805/
https://www.ncbi.nlm.nih.gov/pubmed/26826205
http://dx.doi.org/10.1212/WNL.0000000000002395

Ejemplares similares